Identification of miRSNPs associated with the risk of multiple myeloma-Reference-Cited by-同舟云学术

Identification of miRSNPs associated with the risk of multiple myeloma

Published:2016-11-09 Issue:3 Volume:140 Page:526-534
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Macauda Angelica¹²,Calvetti Diego¹²,Maccari Giuseppe³,Hemminki Kari⁴,Försti Asta⁴,Goldschmidt Hartmut⁵,Weinhold Niels⁵,Houlston Richard⁶,Andersen Vibeke⁷⁸,Vogel Ulla⁹,Buda Gabriele¹⁰,Varkonyi Judit¹¹,Sureda Anna¹²,Martinez Lopez Joaquin¹³,Watek Marzena¹⁴,Butrym Aleksandra¹⁵,Sarasquete Maria Eugenia¹⁶,Dudziński Marek¹⁷,Jurczyszyn Artur¹⁸,Druzd-Sitek Agnieszka¹⁹,Kruszewski Marcin²⁰,Subocz Edyta²¹,Petrini Mario¹⁰,Iskierka-Jażdżewska Elzbieta²²,Raźny Malgorzata²³,Szombath Gergely¹¹,Marques Herlander²⁴²⁵,Zawirska Daria¹⁸,Chraniuk Dominik²⁶,Halka Janusz²¹,Hove Jacobsen Svend Erik²⁷,Mazur Grzegorz²⁸,García Sanz Ramón¹⁶,Dumontet Charles²⁹,Moreno Victor³⁰,Stępień Anna³¹,Beider Katia³²,Pelosini Matteo³³,Manuel Reis Rui²⁴²⁵³⁴,Krawczyk-Kulis Malgorzata³⁵,Rymko Marcin²⁶,Avet-Loiseau Hervé³⁶,Lesueur Fabienne³⁷³⁸³⁹⁴⁰,Grząśko Norbert⁴¹,Ostrovsky Olga³²,Jamroziak Krzysztof⁴²,Vangsted Annette J.⁴³,Jerez Andrés⁴⁴,Tomczak Waldemar⁴⁵,Zaucha Jan Maciej⁴⁶,Kadar Katalin¹¹,Sainz Juan⁴⁷,Nagler Arnon³²,Landi Stefano¹,Gemignani Federica¹,Canzian Federico²

Affiliation:

1. Department of Biology; University of Pisa; Pisa Italy

2. Genomic Epidemiology Group, German Cancer Research Center (DKFZ); Heidelberg Germany

3. The Pirbright Institute, Pirbright; Woking Surrey GU24 0NF United Kingdom

4. Division of Molecular Genetic Epidemiology; German Cancer Research Center (DKFZ); Heidelberg Germany

5. Department of Internal Medicine V; University of Heidelberg; Heidelberg Germany

6. Division of Genetics and Epidemiology; The Institute of Cancer Research; London United Kingdom

7. Institute of Regional Health Research, and Institute of Molecular Medicine, Faculty of Health Sciences, University of Southern Denmark; Odense Denmark

8. Research Unit of Molecular Diagnostics and Clinical Research, Laboratory Center, Hospital of Southern Jutland; Aabenraa Denmark

9. National Research Centre for the Working Environment; Copenhagen DK-2100 Denmark

10. UO Hematology, Department of Internal and Experimental Medicine; University of Pisa; Pisa Italy

11. Department of Hematology; Semmelweis University; Budapest Hungary

12. Department of Hematology; Catalan Institute of Oncology (ICO) and IDIBELL; Barcelona Spain

13. Department of Hematology; Hospital Universitario 12 de Octubre, Complutense School of Medicine, CNIO; Madrid Spain

14. Holycross Medical Center; Kielce Poland

15. Medical University; Wrocław Poland

16. Department of Hematology; University Hospital of Salamanca; Salamanca Spain

17. Department of Hematology; Specialist District Hospital; Rzeszow Poland

18. Department of Hematology; Cracow University Hospital; Cracow Poland

19. Department of Lymphoid Malignancies Maria Sklodowska-Curie Memorial Institute and Oncology Centre Warsaw; Warsaw Poland

20. Department of Hematology; University Hospital; Bydgoszcz Poland

21. Department of Hematology; Military Institute of Medicine; Warsaw Poland

22. Department of Hematology; Medical University of Lodz; Łódź Poland

23. Department of Hematology; Rydygier Hospital; Cracow Poland

24. Life and Health Sciences Research Institute (ICVS), School of Health Sciences, University of Minho; Braga Portugal

25. ICVS/3B's-PT Government Associate Laboratory; Braga Portugal

26. Department of Hematology; Copernicus Hospital; Torun Poland

27. Clinic of Immunology, Laboratory Center, Hospital of Southern Jutland; Sønderborg Denmark

28. Department of Internal Diseases, Hypertension and Occupational Medicine; Medical University; Wroclaw Poland

29. INSERM UMR 1052/CNRS 5286, Université Claude Bernard Lyon I; Lyon 69622 France

30. Cancer Prevention and Control Program, Catalan Institute of Oncology (ICO), IDIBELL, CIBERESP and Department of Clinical Sciences, Faculty of Medicine; University of Barcelona; Barcelona Spain

31. Laboratory of Clinical and Transplant Immunology and Genetics; Copernicus Memorial Hospital; Łódź Poland

32. Chaim Sheba Medical Center; Tel-Hashomer Ramat Gan Israel

33. Azienda USL Toscana Nord Ovest; U.O Dipartimento di Ematologia; Livorno, Italy

34. Barretos Cancer Hospital; Molecular Oncology Research Center; Barretos Brazil

35. Department of Hematology and Bone marrow Transplantation; Silesian Medical University; Katowice Poland

36. Laboratoire d'hématologie, Pôle biologie; Institut Universitaire du Cancer de Toulouse-Oncopole 1; Avenue Irène Joliot-Curie, Toulouse 31059 France

37. Institut Curie; 26 rue d'Ulm Paris F-75005 France

38. PSL Research University; Paris F-75005 France

39. Inserm, U900; Paris F-75005 France

40. Mines Paris Tech; Fontainebleau, Paris F-77305 France

41. Department of Hematology; St. John's Cancer Center; Lublin Poland

42. Department of Hematology; Institute of Hematology and Transfusion Medicine; Warsaw Poland

43. Department of Haematology, Rigshospitalet; Copenhagen University; Copenhagen Denmark

44. Department of Hematology and Medical Oncology; IMIB, University Hospital Morales Meseguer; Murcia Spain

45. Department of Hematooncology and Bone Marrow Transplantation; Medical University of Lublin; Lublin Poland

46. Department of Hematology; Sea Hospital; Gdynia Poland

47. Centro Pfizer, Universidad de Granada, Junta de Andalucía de Genómica e Investigación Oncológica (GENYO); Granada Spain

Funder

Gerencia Regional de Salud de la Junta de Castilla y Léon

Instituto de Salud Carlos III

Catalan Government DURSI

FEDER funds

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/ijc.30465/fullpdf

Reference35 articles.

1. Occupation and multiple myeloma: an occupation and industry analysis;Gold;Am J Ind Med,2010

2. Patterns of hematologic malignancies and solid tumors among 37,838 first-degree relatives of 13,896 patients with multiple myeloma in Sweden;Kristinsson;Int J Cancer,2009

3. Polymorphisms in xenobiotic transporters ABCB1, ABCG2, ABCC2, ABCC1, ABCC3 and multiple myeloma risk: a case-control study in the context of the International Multiple Myeloma rESEarch (IMMEnSE) consortium;Martino;Leukemia,2012

4. Common variation at 3p22.1 and 7p15.3 influences multiple myeloma risk;Broderick;Nat Genet,2012

5. The CCND1 c.870G>A polymorphism is a risk factor for t(11;14)(q13;q32) multiple myeloma;Weinhold;Nat Genet,2013

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. MiR-146a rs2910164 (G/C) polymorphism is associated with the development and prognosis of acute coronary syndromes: an observational study including case control and validation cohort;Journal of Translational Medicine;2023-05-15

2. Data Integration for Big Data analytics to identify the gaps in Rheumatoid Arthritis Genomics in a Post-GWAS era;2022 2nd International Conference on Advance Computing and Innovative Technologies in Engineering (ICACITE);2022-04-28

3. Association of Genetic Variants Affecting microRNAs and Pancreatic Cancer Risk;Frontiers in Genetics;2021-08-30

4. Common gene variants within 3′‐untranslated regions as modulators of multiple myeloma risk and survival;International Journal of Cancer;2020-11-20

5. The effects of MicroRNA deregulation on pre-RNA processing network in multiple myeloma;Leukemia;2019-06-10